View All

In a significant development for the pharmaceutical and clinical trial industries, we proudly announce a strong collaborative effort of Eurofins companies dedicated to clinical trial testing in support of drug and vaccine development. Under the new brand of Eurofins Clinical Trial Solutions, we emphasize our expanded commitment to offering global comprehensive, collaborative solutions for the complex challenges of modern drug development.

Gene therapy offers groundbreaking solutions by delivering genetic material to correct or compensate for flawed proteins. While AAV vectors have shown significant potential due to their improved safety profile and tissue specificity, challenges remain—particularly when it comes to managing immune responses.

Monitoring CAR T-cells post-infusion in clinical trials using flow cytometry requires a robust, standardized assay to generate valuable and reliable data for therapy monitoring and biomarker identification.

Strategies for the Modernization of Legacy Transfer Methods

Putting Cell Counting in Context (of use): Analytical Measurements Supporting Cellular Therapies

RNASeq: Illuminating Biomarker Landscapes for Precision Medicine - A Comparative Exploration of Multiplex Gene Profiling Technologies

Global Harmonization of PCR: An Initial Study with Six World Health Organization (WHO) Reference Strains

This white paper explores the qualification studies of the NanoString nCounter PanCancer IO 360 Gene Expression Panel, emphasizing its role in immuno-oncology research. The panel examines 770 genes across 16 pathways, providing insights into tumor-immune interactions and identifying potential biomarkers for immunotherapy.

June 26, 2024

Ruqi Wang's presentation will review the complexities involved in evaluating immunogenicity for cell and gene therapies. It will also provide valuable insights into the use of flow cytometry in ADA and NAb assays to assess humoral immune response.

In an exclusive interview, study author Dr. Karina Eterovic, R&D Director of Oncology Diagnostics at Eurofins Viracor BioPharma, discusses the complex interplay between clonal hematopoiesis and cancer genomics, in the context of precision of cancer diagnosis and treatment.